Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    • Home
    • AYUSH
    • Ministry of AYUSH...

    Ministry of AYUSH commercialized Ayurvedic Drugs for various ailments

    Medical Dialogues BureauWritten by Medical Dialogues Bureau Published On 2018-02-16T10:15:43+05:30  |  Updated On 16 Feb 2018 10:15 AM IST
    Ministry of AYUSH commercialized Ayurvedic Drugs for various ailments

    The Minister of State (Independent Charge) for AYUSH, Shri Shripad Yesso Naik in a written reply to a question in Rajya Sabha said Central Council for Research in Ayurvedic Sciences (CCRAS) under the Ministry of AYUSH has developed and commercialized ayurvedic drugs for various other ailments including diabetes, Rheumatoid Arthritis, Dengue, Cancer, Chronic Kidney Diseases.


    The Central Council for Research in Ayurvedic Sciences (CCRAS), an autonomous body under the Ministry of AYUSH is actively involved in scientific process of drug development adopting prevalent guidelines such as Good Clinical Practices Guidelines for ASU drugs (GCP-ASU), Ministry of AYUSH and National ethical guidelines for Bio-Medical Research (ICMR), WHO guidelines for traditional medicines etc. as per requirement and as feasible through its peripheral institutes. Council through its drug development program is undertaking the development of new formulations/drugs taking leads from Ayurvedic literature through a systematic process of drug development. viz standardization, preclinical safety & clinical study as per requirement.


    CCRAS has developed and commercialized the following two drugs:




    1. AYUSH 82 An Anti Diabetic Ayurvedic Formulation

    2. AYUSH SG An Anti-Rheumatoid Arthritis preparation.


    CCRAS has also undertaken the development of the following coded formulations which are at different phases of drug development:-




    1. AYUSH Manas for Mental retardation/cognitive deficit

    2. AYUSH QOL 2C for improving Quality of Life of Cancer patients

    3. AYUSH Rasayan A & B in geriatric health

    4. AYUSH C1 Oil for wound healing

    5. AYUSH PJ-7 for Dengue fever

    6. AYUSH M-3 for a Migraine

    7. AYUSH SL for Filariasis

    8. AYUSH A for Bronchial Asthma

    9. AYUSH D for Type II Diabetes Mellitus

    10. Carctol S for Cancer

    11. AYUSH K1 for Chronic Kidney Diseases

    ayurvedic drugsAyushBronchial AsthmacancerCCRASCentral Council for Research in Ayurvedic SciencesChronic Kidney DiseasesDenguediabetesdrug developmentICMRRajya Sabharheumatoid arthritisWHO
    Source : Press Release

    Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2020 Minerva Medical Treatment Pvt Ltd

    Medical Dialogues Bureau
    Medical Dialogues Bureau

      Medical Dialogues Bureau consists of a team of passionate medical/scientific writers, led by doctors and healthcare researchers.  Our team efforts to bring you updated and timely news about the important happenings of the medical and healthcare sector. Our editorial team can be reached at editorial@medicaldialogues.in. Check out more about our bureau/team here

      Show Full Article
      Next Story
      Similar Posts
      NO DATA FOUND

      Popular Stories

      • Email: info@medicaldialogues.in
      • Phone: 011 - 4372 0751

      Website Last Updated On : 13 Oct 2022 5:14 AM GMT
      Company
      • About Us
      • Contact Us
      • Our Team
      • Reach our Editor
      • Feedback
      • Submit Article
      Ads & Legal
      • Advertise
      • Advertise Policy
      • Terms and Conditions
      • Privacy Policy
      • Editorial Policy
      • Comments Policy
      • Disclamier
      Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

      Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

      © 2025 - Medical Dialogues. All Rights Reserved.
      Powered By: Hocalwire
      X
      We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok